TherapeuticsMD   Report issue

For profit Phase 1 Phase 3
Founded: Boca Raton FL United States (2008)

Organization Overview

First Clinical Trial
2013
NCT02449902
First Marketed Drug
2018
estradiol (progynon depot)
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

TherapeuticsMD | THERAPEUTICSMD INC

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Amenorrhea (Phase 3)

Atrophy (Phase 3)

Dyspareunia (Phase 3)

Neoplasm Metastasis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 7
  • # of Trial APIs: 6